NovAccess Global Appoints Dr. Roscoe M. Moore, Jr. to Scientific Advisory Board

CLEVELAND, OH / ACCESSWIRE / November 10, 2023 / NovAccess Global Inc. (OTCQB:XSNX), a preclinical biomedical company developing novel immunotherapies for brain tumor patients, today announced the appointment of Dr. Roscoe M. Moore, Jr., to its Scientific ...

Related Keywords

Michigan ,United States ,White House ,District Of Columbia ,C Everett Koop ,Dwaink Irvin ,Roscoem Moore Jr , ,Novaccess Global Inc ,Securities Exchange ,Tuskegee Institute ,Johns Hopkins University ,Darrow Associates ,Master Of Public Health ,University Of Michigan ,Us National Institutes Of Health ,Human Services ,United States Department Of Health ,Tuskegee University ,Securities Exchange Commission ,Novaccess Global ,Scientific Advisory ,Commissioned Corps ,United States Public Health Service ,Assistant United States Surgeon ,Novaccess Global Scientific Advisory Board ,Scientific Advisory Board ,Chief Executive Officer ,Access Global ,White House Cancer Moonshot ,United States Department ,Assistant United States Surgeon General ,Rear Admiral ,Immediate Office ,Chief Veterinary Medical Officer ,Surgeon General ,Veterinary Medicine ,Public Health ,Johns Hopkins ,Honoris Causa ,Orphan Drug ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Relations Contact ,Cdr Moore ,Roscoem Moore ,Dr ,United States Surgeon General ,Oscoem Moore Jr ,Brain Tumor Patients ,Biomedical Company ,Public Health Service ,